1,3,4-oxadiazoles with effective anti-mycobacterial activity
Letters in Applied Microbiology · 2025
DOI: 10.1093/lambio/ovaf029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Letters in Applied Microbiology, 2025. Verfasst von Patrícia de Mattos Andriato und 10 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program of Biosciences and Physiopathology, Department of Clinical Analysis and Biomedicine, State University of Maringá, Maringá, PR, 87020…. Hauptthemen laut MEDLINE: Oxadiazoles, Mycobacterium tuberculosis, Antitubercular Agents, Nontuberculous Mycobacteria. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
The search for new drugs to treat tuberculosis and nontuberculous mycobacteria (NTM)-caused diseases is still desired. This is the first study aimed at determining the activity of two innovative synthetic 1,3,4-oxadiazole molecules, (4-[cyclohexyl(ethyl) sulfamoyl]-N-[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]benzamide), namely LMM11, and ((N-cyclo-hexyl-N-ethylsulfamoil)-N-(5- (4-fluorophenyl)-1,3,4-oxadiazol-2-il) benzamide), namely LMM6, against Mycobacterium tuberculosis and nontuberculous mycobacteria, and their ability to present synergism in activity against M. tuberculosis when combined with anti-TB drugs. In vitro cytotoxicity studies were conducted in HeLa and VERO cells. The minimum inhibitory concentration (MIC) and combinatory effect were carried out in M. tuberculosis H37Rv and resistant isolates, NTM, and other genera of bacteria. The LMM6 and LMM11 MIC ranged from 8.27 to 33.07 µM and 15.58 to 70.30 µM in M. tuberculosis, respectively. LMM6 showed activity against M. smegmatis mc2 155 (8.25 μM), M. szulgai (2.05 μM), and M. kansasii (66.03 μM), while LMM11 showed activity against M. szulgai (8.77 μM), and M. smegmatis (70.19 μM). Synergism and modulatory activity of LMM6 and LMM11 with anti-TB drugs were observed, and they showed to be more selective for mycobacteria than HeLa and VERO cells. Both new oxadiazoles showed activity against mycobacteria, in fact, more pronounced against M. tuberculosis, and seem to bring light to the synthesis of new antimicobacterial.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Program of Biosciences and Physiopathology, Department of Clinical Analysis and Biomedicine, State University of Maringá, Maringá, PR, 87020- 900, Brazil.
- Graduate Program in Health Sciences, State University of Maringá, Maringá, PR, 87020- 900, Brazil.
- Department of Clinical Analysis and Biomedicine, State University of Maringá, Maringá, PR, 87020- 900, Brazil.
- Emeritus Researcher, LORIA, Lorraine University, Nancy, 54506, France.
ORCID-Profile: Rosilene Fressatti Cardoso
Zitieren
APA
Andriato, P. M., Baldin, V. P., de Almeida, A. L., Sampiron, E. G., de Vasconcelos, S. S. N., Caleffi-Fercioli, K. R., Scodro, R. B. L., Meneguello, J. E., Maigret, B., Kioshima, É. S., & Cardoso, R. F. (2025). 1,3,4-oxadiazoles with effective anti-mycobacterial activity. Letters in Applied Microbiology. https://doi.org/10.1093/lambio/ovaf029
Vancouver
Andriato PM, Baldin VP, de Almeida AL, Sampiron EG, de Vasconcelos SSN, Caleffi-Fercioli KR, et al. 1,3,4-oxadiazoles with effective anti-mycobacterial activity. Letters in Applied Microbiology. 2025. doi:10.1093/lambio/ovaf029
BibTeX
@article{Andriato2025,
author = {Andriato, Patrícia de Mattos and Baldin, Vanessa Pietrowski and de Almeida, Aryadne Larissa and Sampiron, Eloisa Gibin and de Vasconcelos, Sandra Sayuri Nakamura and Caleffi-Fercioli, Katiany Rizzieri and Scodro, Regiane Bertin de Lima and Meneguello, Jean Eduardo and Maigret, Bernard and Kioshima, Érika Seki and Cardoso, Rosilene Fressatti},
title = {1,3,4-oxadiazoles with effective anti-mycobacterial activity},
journal = {Letters in Applied Microbiology},
year = {2025},
doi = {10.1093/lambio/ovaf029}
}
EUVIMED